EMTT Blog

It is time to wrap up our little series on Extracorporeal Magnetotransduction Therapy (EMTT) with the MAGNETOLITH® – STORZ MEDICAL’s new touch-free solution for the treatment of chronic diseases of the musculoskeletal system. To conclude this series, we would like to draw your attention to our new explanatory video:

Prof Dr Karsten Knobloch from Hannover, Germany, is also among the convinced users of Extracorporeal Magnetotransduction Therapy (EMTT) with the MAGNETOLITH®. 

»For me, MAGNETOLITH® complements the combined shock wave therapy in a congenial way. In my sports practice, I see clear synergistic effects on diseased tendons and bones that result in accelerated tissue healing. This is of immense importance, especially for the top athletes I look after.«

We continue our series on Extracorporeal Magnetotransduction Therapy (EMTT) with the MAGNETOLITH® with another user’s opinion. This time from Michael Strøm, Denmark:

»During the last six months, I have successfully conducted around 950 EMTT treatments with the MAGNETOLITH® within a wide spectrum of different indications. In most of the cases the EMTT treatment was combined with ESWT, in order to work as efficiently as possible.

In our little series on Extracorporeal Magnetotransduction Therapy (EMTT) with the MAGNETOLITH® we have talked a lot about the advantages of the new therapy option. But what do the experts say who are already working with EMTT? What is their verdict? Let’s start with Prof Ludger Gerdesmeyer from Kiel, Germany.

»At my clinic and practice, I use the MAGNETOLITH® primarily for degenerative joint, muscle and tendon disorders, but also for inflammatory forms of musculoskeletal disorders, both as a stand-alone therapy and as a supplement to extracorporeal shock wave therapy (ESWT).

Placebo-controlled studies published in 2017 & 2018 show the huge potential of EMTT – both as a stand-alone therapy and as a supplement to focused shock wave therapy (ESWT). While ESWT uses high energy acoustic effects on a local treatment area, EMTT uses high energy electromagnetic effects on a regional treatment area. ESWT & EMTT have an additive profile and thus also work great in combination or as parts of a multimodal therapy approach.

The MAGNETOLITH® system is a joy to work with. It features a modern design and is extremely easy to use. The powerful applicator ensures optimum transmission of the therapeutically effective magnetic field to the patient. Its effective cooling system enables interruption-free therapy in continuous operation even at the highest device output. Thanks to the flexible holding arm, the applicator can be placed in any position. The individual joints are secured exactly with one simple movement.

EMTT treatment with the MAGNETOLITH® requires little effort, is non-invasive and practically free from side effects. For patients, the treatment is comfortable and straightforward: The therapy loop is positioned over the area of pain while the patient remains fully clothed – direct skin contact is not necessary. Users can also employ the practical holding arm for fatigue-free treatment.

Disorders of the musculoskeletal system are the most common cause of (chronic) pain around the globe. These disorders include back pain and osteoarthritis as well as typical sports injuries such as inflammation of the tendons and joints. Extracorporeal Magnetotransduction Therapy (EMTT) with the MAGNETOLITH® system offers a wide range of therapeutic applications:

Extracorporeal Magnetotransduction Therapy (EMTT) can cause a positive cell modulation. Every cell undergoes chemical reactions that serve to generate energy. The prerequisite for this is membrane permeability. A stable cell membrane ensures permeability for vital substances. A pathological change leads to dysfunction – a metabolic disorder that can ultimately lead to disease. The chemical reactions of the cell potential can be positively influenced by EMTT. The sodium-potassium pump can be reactivated, and physiological cell processes can be normalized.

During Extracorporeal Magnetotransduction Therapy (EMTT), painful areas of the body are treated with high-energy magnetic pulses, the field strength of which lies within the therapeutically effective range – 10 mT (millitesla) and upward. With this pulse intensity, it is possible to achieve a therapeutic effect in the cell. The generated energy is transferred via an applicator to the body areas to be treated.

Extracorporeal Magnetotransduction Therapy (EMTT) differs from other general forms of magnetic field therapy or PEMF (pulsed electromagnetic field therapy) in its higher oscillation frequency (100 – 300 kHz) and magnetic field strength (> 10 mT), resulting in a strong »effective transduction power«. It can be assumed that the faster the magnetic field pulses or the higher the effective transduction power, the more pronounced the bioelectrical activity in the organism will be. The high oscillation frequency also enables a high penetration depth (up to 18 cm) and a large range of applications.

Extracorporeal Magnetotransduction Therapy (EMTT) is a non-invasive treatment solution that opens up new possibilities in regeneration and rehabilitation. The areas of application include chronic diseases of the musculoskeletal system such as lower back pain, arthrosis (osteoarthritis), or inflammation of the tendons and joints. The EMTT therapy device – STORZ MEDICAL’s MAGNETOLITH® – was launched in 2020. More than 100 devices have already been installed and the patients are loving it!